Europe’s CHMP confirms ranitidine suspension

21 September 2020 - Deborah Wilkes

Archived

Europe’s Committee for Medicinal Products for Human Use (CHMP) has confirmed its recommendation that all medicines containing ranitidine should be suspended in the European Union.

Click tags below for more information on topics:

EMA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: